Loson H 50mg/12.5mg Tablet
Manufacturer
Patson Laboratories Pvt Ltd
Salt Composition
Losartan (50mg) + Hydrochlorothiazide (12.5mg)
Key Information
Short Description
Loson H 50mg/12.5mg Tablet is a combination of two medicines that helps to control high blood pressure in different ways.
Dosage Form
Tablet
Introduction
Loson H 50mg/12.5mg Tablet is a combination of two medicines that helps to control high blood pressure in different ways. If high blood pressure is not treated it can lead to heart attacks, strokes and kidney failure.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Loson H 50mg/12.5mg Tablet may be taken with or without food but it is better to take it at a fixed time.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Loson H 50mg/12.5mg Tablet.
Breastfeeding Warning
Loson H 50mg/12.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Loson H 50mg/12.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
How it works
Loson H 50mg/12.5mg Tablet is a combination of two medicines: ...
Quick Tips
You have been prescribed Loson H 50mg/12.5mg Tablet for the treatment of high blood pressure. It can be taken with or without food. Loson H 50mg/12.5mg Tablet may cause dehydration. Drink plenty of fluids and inform your doctor if you develop extreme thirst, very dry mouth or muscle weakness. It may cause dizziness. Get up slowly when rising from a sitting or lying position. Use of Loson H 50mg/12.5mg Tablet during pregnancy or breastfeeding is unsafe.
Related Medicines
Losar-H Tablet
Tozaar-H Tablet
Losartas-HT Tablet
Angizaar H Tablet
Repace H Tablet
Losacar-H Tablet
Losakind-H Tablet
Losaneed-H 50/12.5 Tablet
Losastar H 50mg/12.5mg Tablet
Asart HT 50 mg/12.5 mg Tablet
Frequently asked questions
What special instructions are there regarding the storage and disposal of this medication?
Store this medication in its original container, tightly sealed. Refer to the packaging or label for specific storage instructions. Do not use the medication if it is expired or has changed color or smell. Dispose of unused medication properly to prevent accidental ingestion by children, pets, or other individuals.
Can I experience dizziness after taking Loson H 50mg/12.5mg Tablet?
Some users may experience lightheadedness or dizziness upon sudden elevation from a lying or sitting position while using Loson H 50mg/12.5mg Tablet. It is essential to take it slowly when shifting postures to minimize the risk of dizziness and fainting.
Is Loson H 50mg/12.5mg Tablet safe during pregnancy?
Loson H 50mg/12.5mg Tablet is not recommended for use during pregnancy. Its use may pose a risk to the developing fetus, potentially causing harm and even death. If you become pregnant while using this medication, immediately discontinue its use and consult your healthcare provider. Your doctor may recommend alternative methods to manage blood pressure.
What lifestyle changes are recommended when taking Loson H 50mg/12.5mg Tablet?
Making positive lifestyle changes can benefit your health while using Loson H 50mg/12.5mg Tablet. Avoid smoking as it increases the risk of heart attack and stroke. If you are overweight or obese, consider weight loss efforts. Maintain a healthy diet by consuming fruits and vegetables daily. Regular physical activity strengthens your heart and reduces the risk of future heart attacks.
Can I stop taking Loson H 50mg/12.5mg Tablet if I feel well?
No, continue using Loson H 50mg/12.5mg Tablet as prescribed by your healthcare provider even when you feel well. Stopping this medication abruptly may lead to serious complications such as heart attack or stroke.
